Vir Biotechnology, Inc. (VIR) Stock Grade

About Vir Biotechnology, Inc.'s fundamentals

Vir Biotechnology is a small-cap biotech company with a market capitalization of $835.3 million that reported a significant net loss in its latest fiscal year, resulting in a negative net margin of -638.9%. The company's revenue contracted 7.6% year-over-year, indicating declining sales momentum. With no dividend payments and unprofitable operations, Vir is dependent on cash reserves and potential financing to fund ongoing research and development activities. Standard valuation metrics like P/E ratio and return on equity are not applicable due to the company's loss-making status.